Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

The evaluation of AZ66, an optimized sigma receptor antagonist, against methamphetamine-induced dopaminergic neurotoxicity and memory impairment in mice.

Seminerio MJ, Hansen R, Kaushal N, Zhang HT, McCurdy CR, Matsumoto RR.

Int J Neuropsychopharmacol. 2013 Jun;16(5):1033-44. doi: 10.1017/S1461145712000831. Epub 2012 Aug 29.

PMID:
22932447
2.

σ Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation.

Robson MJ, Seminerio MJ, McCurdy CR, Coop A, Matsumoto RR.

Pharmacol Rep. 2013;65(2):343-9.

3.

Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo.

Kaushal N, Seminerio MJ, Robson MJ, McCurdy CR, Matsumoto RR.

Eur Neuropsychopharmacol. 2013 Aug;23(8):960-71. doi: 10.1016/j.euroneuro.2012.08.005. Epub 2012 Aug 24.

4.

Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: Evidence from in vivo and in vitro studies.

Matsumoto RR, Shaikh J, Wilson LL, Vedam S, Coop A.

Eur Neuropsychopharmacol. 2008 Dec;18(12):871-81. doi: 10.1016/j.euroneuro.2008.07.006. Epub 2008 Aug 27.

5.

CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice.

Kaushal N, Seminerio MJ, Shaikh J, Medina MA, Mesangeau C, Wilson LL, McCurdy CR, Matsumoto RR.

Neuropharmacology. 2011 Oct-Nov;61(5-6):992-1000. doi: 10.1016/j.neuropharm.2011.06.028. Epub 2011 Jul 7.

6.

Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine.

Seminerio MJ, Robson MJ, Abdelazeem AH, Mesangeau C, Jamalapuram S, Avery BA, McCurdy CR, Matsumoto RR.

AAPS J. 2012 Mar;14(1):43-51. doi: 10.1208/s12248-011-9311-8. Epub 2011 Dec 20.

7.

Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice.

Seminerio MJ, Kaushal N, Shaikh J, Huber JD, Coop A, Matsumoto RR.

Pharmacol Biochem Behav. 2011 Mar;98(1):12-20. doi: 10.1016/j.pbb.2010.11.023. Epub 2010 Dec 2.

8.

Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1β mRNA expression in the hypothalamus.

Seminerio MJ, Robson MJ, McCurdy CR, Matsumoto RR.

Eur J Pharmacol. 2012 Sep 15;691(1-3):103-9. doi: 10.1016/j.ejphar.2012.07.029. Epub 2012 Jul 20.

9.
10.

Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.

Granado N, Ares-Santos S, Oliva I, O'Shea E, Martin ED, Colado MI, Moratalla R.

Neurobiol Dis. 2011 Jun;42(3):391-403. doi: 10.1016/j.nbd.2011.01.033. Epub 2011 Feb 15.

PMID:
21303698
12.
13.
14.

Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.

Itzhak Y, Gandia C, Huang PL, Ali SF.

J Pharmacol Exp Ther. 1998 Mar;284(3):1040-7.

15.

Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine.

Ke JJ, Chen HI, Jen CJ, Kuo YM, Cherng CG, Tsai YP, Ho MC, Tsai CW, Yu L.

Toxicol Appl Pharmacol. 2008 Mar 1;227(2):239-47. Epub 2007 Nov 1.

PMID:
18076959
16.

Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.

Bourque M, Liu B, Dluzen DE, Di Paolo T.

Biochem Pharmacol. 2007 Nov 1;74(9):1413-23. Epub 2007 Jul 14.

PMID:
17825264
17.

SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation.

Robson MJ, Turner RC, Naser ZJ, McCurdy CR, O'Callaghan JP, Huber JD, Matsumoto RR.

Exp Neurol. 2014 Apr;254:180-9. doi: 10.1016/j.expneurol.2014.01.020. Epub 2014 Feb 6.

18.

Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine.

Izquierdo A, Belcher AM, Scott L, Cazares VA, Chen J, O'Dell SJ, Malvaez M, Wu T, Marshall JF.

Neuropsychopharmacology. 2010 Jan;35(2):505-14. doi: 10.1038/npp.2009.155.

19.
20.

Supplemental Content

Support Center